Marrone Bio Innovations Reports Second Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- Houthi attack on Saudi airport kills 12, over 300 wounded, authorities say
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
Marine Bio (MBII) Reports In-Line Q2 EPS, Enters Microbial Product Development Pact with Albaugh
August 9, 2016 4:46 PM EDTMarine Bio (NASDAQ: MBII) reported Q2 EPS of ($0.28), in-line with the analyst estimate of ($0.28). Revenue for the quarter came in at $5 million versus the consensus estimate of $4.61 million.
Albaugh, LLC and Marrone Bio Innovations, Inc. (MBI) announced the companies have signed an exclusive agreement to develop and market one of MBIs microbial products, a proprietary microbial biopesticide with insecticidal and nematicidal properties, for seed treatment applications.
Dr. Pam Marrone, Founder and... More



